AI in Healthcare: Complete Guide

Healthcare AI Landscape

Medical Imaging AI Architecture

Drug Discovery AI Pipeline

Clinical Decision Support System

HIPAA Compliance & Data Privacy

Interview Questions

1. What are the main challenges of deploying AI in healthcare compared to other industries?

Answer: Healthcare AI faces unique challenges: regulatory compliance (FDA/EMA approval required for SaMD), patient safety (errors can be life-threatening), data privacy (HIPAA/GDPR strict requirements), explainability (clinicians need to understand reasoning), interoperability (HL7/FHIR standards, EHR integration), and validation (multi-site external validation required). Unlike other industries, healthcare AI must undergo rigorous clinical trials and post-market surveillance.

2. How does federated learning help address privacy concerns in medical AI?

Answer: Federated learning allows hospitals to collaboratively train AI models without sharing patient data. Each institution trains locally on their data, sharing only model updates (gradients) with a central server. This preserves privacy while leveraging diverse datasets. Benefits: HIPAA compliance, larger effective training data, reduced bias from diverse populations. Challenges: Communication overhead, handling non-IID data distributions, and ensuring differential privacy guarantees.

3. What is the difference between AI-assisted diagnosis and autonomous AI in healthcare?

Answer: AI-assisted diagnosis provides recommendations to clinicians who make final decisions (human-in-the-loop). Autonomous AI makes decisions without physician oversight (e.g., IDx-DR for diabetic retinopathy screening). Regulatory requirements differ: assistance tools need less validation, while autonomous systems require Level 1 evidence from clinical trials. Most healthcare AI is designed as assistive to maintain physician oversight and liability.

4. Explain the concept of "clinical-grade" AI and how it differs from research prototypes.

Answer: Clinical-grade AI requires: 1) Multi-site validation across diverse patient populations, 2) Prospective clinical trials (not just retrospective), 3) FDA/EMA regulatory clearance, 4) Integration with clinical workflows (EHR, PACS), 5) Post-market surveillance for drift detection, 6) Explainability for clinical decision audit, 7) Bias testing across demographics. Research prototypes typically only demonstrate performance on held-out test sets without real-world validation.

5. How do you handle class imbalance in medical imaging datasets?

Answer: Medical datasets often have rare conditions (e.g., 1% positive cases). Solutions: Data augmentation (rotation, flipping, elastic deformation), Oversampling minority class (SMOTE for images), Undersampling majority class, Focal loss (down-weight easy examples), Class-weighted loss functions, Transfer learning from pretrained models, Ensemble methods combining multiple models, and Synthetic data generation using GANs. Also consider metrics beyond accuracy: sensitivity, specificity, F1, AUC-PR.

6. What role does NLP play in clinical decision support systems?

Answer: NLP enables: Clinical note parsing (unstructured → structured), Named entity recognition (medications, diagnoses, procedures), Temporal relation extraction (disease progression timeline), De-identification (remove PHI for research), ICD-10 auto-coding (billing automation), Drug interaction detection from notes, and Patient phenotype extraction for cohort selection. Modern clinical NLP uses domain-specific models like ClinicalBERT, PubMedBERT, or Med-PaLM.

7. How do you ensure AI fairness across different patient demographics?

Answer: Healthcare AI bias can worsen health disparities. Mitigation: Diverse training data (race, age, sex, socioeconomic status), Bias auditing (measure performance across subgroups), Fairness constraints in training (equalized odds, demographic parity), Synthetic minority oversampling, Domain adaptation for underrepresented populations, External validation on diverse datasets, and Continuous monitoring post-deployment. FDA now requires demographic subgroup analysis for clearance.

8. What are the key components of a medical imaging AI deployment pipeline?

Answer: Production pipeline: DICOM ingestion (standard format handling), Preprocessing (windowing, normalization, reorientation), Model inference (GPU-optimized serving), Post-processing (confidence calibration, NMS), Integration (PACS/RIS connection via DICOM/HL7), Radiologist review (worklist prioritization), Result storage (structured reporting), Monitoring (performance drift, A/B testing), and Audit logging (regulatory compliance). Must handle edge cases: motion artifacts, rare pathologies, equipment variability.

KnowledgeCheck

1. What does HIPAA require for de-identification of patient data?

   • a) Remove only patient names
   • b) Remove 18 identifiers using Safe Harbor method
   • c) Encrypt data with patient key
   • d) Store data only in US servers

2. Which technique allows training AI models across hospitals without sharing patient data?

   • a) Data pooling
   • b) Transfer learning
   • c) Federated learning
   • d) Data augmentation

3. What is the primary purpose of the FDA's SaMD classification?

   • a) To speed up drug approvals
   • b) To regulate software as a medical device
   • c) To manage hospital IT systems
   • d) To standardize medical coding

4. Which metric is most important for rare disease detection in medical imaging?

   • a) Accuracy
   • b) Specificity
   • c) Sensitivity/Recall
   • d) Precision

5. What does "clinical-grade" AI require that research prototypes do not?

   • a) Higher accuracy on test sets
   • b) Multi-site prospective validation and regulatory clearance
   • c) Larger model parameters
   • d) Faster inference speed

6. What is the main advantage of using U-Net architecture in medical imaging?

   • a) Faster training than CNNs
   • b) Skip connections for precise segmentation
   • c) No need for labeled data
   • d) Works only on 2D images

Answers: 1-b, 2-c, 3-b, 4-c, 5-b, 6-b